Nasdaq · Healthcare
ALIGN TECHNOLOGY INC (ALGN)
As-reported financials and recent SEC filings for ALIGN TECHNOLOGY INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$4.03B
Net income
$410.4M
Net margin
10.2%
Diluted EPS
$5.65
ROE
10.1%
P/E (TTM)
30.0×
Market cap
$12.78B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B |
| Gross profit | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B |
| Operating income | $545.8M | $607.6M | $643.3M | $642.6M | $976.4M |
| Net income | $410.4M | $421.4M | $445.1M | $361.6M | $772.0M |
| Diluted EPS | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-22
View on EDGAR →SD2026-05-29
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →Go deeper on ALGN
Search ALIGN TECHNOLOGY INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.